Anti-Aging Market Size to Surpass USD 284.8 billion by 2028, exhibiting a CAGR of 4.4% | Report by Transparency Market Research
06 oct. 2023 04h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The anti-aging market is projected to reach US$ 284.8 billion by 2028. Anti-aging market...
GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions
05 oct. 2023 08h45 HE
|
GRI Bio, Inc.
In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in the disease setting Data supports GRI Bio’s...
Exploring the Future of Healthcare: Mobile Hospitals Market Set to Reach USD 52.8 Billion by 2031 - TMR Analysis
15 sept. 2023 08h04 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global mobile hospitals market is projected to flourish at a CAGR of 10% from 2021 to...
[Latest] Global Biofilms Treatment Market Size/Share Worth USD 3.5 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
05 sept. 2023 16h30 HE
|
Custom Market Insights
Austin, TX, USA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biofilms Treatment Market Size, Trends and Insights By Product (Debridement...
Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors
17 août 2023 08h30 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers...
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
16 août 2023 08h00 HE
|
QSAM Biosciences Inc.
AUSTIN, Texas, Aug. 16, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
10 août 2023 08h00 HE
|
US Capital Global
San Francisco, California, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, recently launched an investment opportunity of up to $5 million...
APA Foundation Encourages Action with First Major Mental Health Public Awareness Initiative
09 août 2023 10h00 HE
|
American Psychiatric Association
Washington, D.C., Aug. 09, 2023 (GLOBE NEWSWIRE) -- The American Psychiatric Association Foundation (APAF) launched a transformative awareness campaign that empowers individuals to take the first...
Las Vegas Alcohol Rehab
07 août 2023 10h00 HE
|
Gallus Medical Detox Centers
LAS VEGAS, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gallus Medical Detox Center in Las Vegas, a leading provider of medically supervised detoxification services, is proud to share more on its alcohol detox...
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
31 juil. 2023 16h05 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development...